MXPA02008072A - Composicion farmaceutica. - Google Patents

Composicion farmaceutica.

Info

Publication number
MXPA02008072A
MXPA02008072A MXPA02008072A MXPA02008072A MXPA02008072A MX PA02008072 A MXPA02008072 A MX PA02008072A MX PA02008072 A MXPA02008072 A MX PA02008072A MX PA02008072 A MXPA02008072 A MX PA02008072A MX PA02008072 A MXPA02008072 A MX PA02008072A
Authority
MX
Mexico
Prior art keywords
membrane
nail
solvent
solution
permeation enhancer
Prior art date
Application number
MXPA02008072A
Other languages
English (en)
Spanish (es)
Inventor
Robert J Gyurik
Original Assignee
Bentley Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bentley Pharmaceuticals Inc filed Critical Bentley Pharmaceuticals Inc
Publication of MXPA02008072A publication Critical patent/MXPA02008072A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MXPA02008072A 2000-02-16 2001-02-16 Composicion farmaceutica. MXPA02008072A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18292400P 2000-02-16 2000-02-16
PCT/US2001/005302 WO2001060325A1 (en) 2000-02-16 2001-02-16 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
MXPA02008072A true MXPA02008072A (es) 2004-04-05

Family

ID=22670647

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02008072A MXPA02008072A (es) 2000-02-16 2001-02-16 Composicion farmaceutica.

Country Status (17)

Country Link
EP (1) EP1257248B1 (enExample)
JP (1) JP2005503318A (enExample)
KR (2) KR20030016227A (enExample)
CN (1) CN1422142A (enExample)
AT (1) ATE526917T1 (enExample)
AU (2) AU2001243189B2 (enExample)
BR (1) BR0108438A (enExample)
CA (1) CA2400178A1 (enExample)
HU (1) HUP0204555A3 (enExample)
MA (1) MA26883A1 (enExample)
MX (1) MXPA02008072A (enExample)
NO (1) NO20023866L (enExample)
NZ (1) NZ520749A (enExample)
PL (1) PL357111A1 (enExample)
TW (1) TWI232756B (enExample)
WO (1) WO2001060325A1 (enExample)
ZA (1) ZA200206553B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
GB0203276D0 (en) * 2002-02-12 2002-03-27 Novartis Ag Organic compounds
JP2005538156A (ja) 2002-09-05 2005-12-15 ガルデルマ・ソシエテ・アノニム 爪塗布用溶液
DK2106805T3 (da) * 2003-03-21 2011-08-15 Nexmed Holdings Inc Antifungal neglelak og anvendelsesmetode
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
JP5010125B2 (ja) * 2005-09-02 2012-08-29 有限会社日本健康科学研究センター 水虫治療用フィルム製剤
WO2007056068A2 (en) * 2005-11-02 2007-05-18 Bentley Pharmaceuticals, Inc. Macrocyclic formulations for transmembrane drug delivery
CN101378729B (zh) * 2005-12-14 2013-09-11 扎尔斯制药公司 治疗皮肤症状的制剂和方法
EP1970076A4 (en) * 2005-12-28 2012-12-12 Teikoku Seiyaku Kk PHARMACEUTICAL COMPOSITION FOR APPLYING TO A NAIL
EP2112923A1 (en) 2007-01-22 2009-11-04 Targacept Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
CN102395274B (zh) * 2009-02-13 2014-03-12 托派卡医药股份有限公司 抗真菌制剂
AU2010226476B2 (en) * 2009-03-20 2013-02-07 Stiefel Laboratories, Inc. Fatty acid monoglyceride compositions
GB201021386D0 (en) * 2010-12-16 2011-01-26 Burke Michael H A process for the manufacture of an antifungal nail lacquer
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
KR101580077B1 (ko) * 2015-03-28 2015-12-24 한국콜마주식회사 시크로피록스 함유 네일락카 조성물
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
WO2026046372A1 (en) * 2024-08-30 2026-03-05 Shenzhen Pharmacin Co., Ltd. Compositions for nail conditions and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
US5023252A (en) * 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5731303A (en) * 1985-12-04 1998-03-24 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery compositions
DE3720147A1 (de) 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
EP0503312B1 (fr) * 1991-03-13 1997-01-08 Firmenich Sa Procédé de préparation de la 15-pentadécanolide ou de mélanges riches en cette macrolide
WO1996012467A1 (en) * 1994-10-20 1996-05-02 The Procter & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US5693828A (en) * 1996-05-09 1997-12-02 International Flavors & Fragrances Inc. Process for preparing lactones and intermediates therefor
CA2278328C (en) * 1998-02-09 2008-07-22 Macrochem Corporation Antifungal nail lacquer and method using same
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
US6495124B1 (en) * 2000-02-14 2002-12-17 Macrochem Corporation Antifungal nail lacquer and method using same

Also Published As

Publication number Publication date
EP1257248A1 (en) 2002-11-20
KR20080049148A (ko) 2008-06-03
JP2005503318A (ja) 2005-02-03
CN1422142A (zh) 2003-06-04
HUP0204555A3 (en) 2004-06-28
PL357111A1 (en) 2004-07-12
TWI232756B (en) 2005-05-21
KR20030016227A (ko) 2003-02-26
NO20023866L (no) 2002-10-01
MA26883A1 (fr) 2004-12-20
EP1257248A4 (en) 2007-10-03
EP1257248B1 (en) 2011-10-05
AU4318901A (en) 2001-08-27
ZA200206553B (en) 2003-11-17
WO2001060325A1 (en) 2001-08-23
AU2001243189B2 (en) 2005-06-09
NZ520749A (en) 2004-06-25
NO20023866D0 (no) 2002-08-15
HUP0204555A2 (en) 2003-05-28
CA2400178A1 (en) 2001-08-23
ATE526917T1 (de) 2011-10-15
BR0108438A (pt) 2003-04-01

Similar Documents

Publication Publication Date Title
AU4318901A (en) Pharmaceutical composition
UA27143C2 (uk) Рідка фармацевтичhа композиція в формі аерозолю
CA2548897A1 (en) Endoparasiticidal agents for topical application
CA2278328A1 (en) Antifungal nail lacquer and method using same
EA200000964A1 (ru) Жидкие полимерные композиции для регулируемого выделения биоактивных веществ
DE69401945D1 (de) Einarbeitung eines poly-n-vinylamids in ein transdermales system
JP2005503318A5 (enExample)
MX9708722A (es) Metodos y composiciones para mejorar la permeacion de la piel a los farmacos utilizando mejoradores de la permeacion, cuando los farmacos y/o los mejoradores de la permeacion son inestables en combinacion durante el almacenamiento a largo plazo.
MY101536A (en) Anti-inflammatory and analgesic tape for external use
IS8870A (is) Lyfjablanda sem felur í sér andrógen
MY146252A (en) Method and composition for improving fuel combustion
DK0702712T3 (da) Synergistisk stabiliserede flydende enzymatiske sammensætninger
MY130857A (en) Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents
WO2005099676A3 (en) Transdermal delivery system for use with basic permeation enhancers
EA200401625A1 (ru) Стабилизированные фармацевтические композиции на основе полиоксиэтилированного касторового масла и способ их получения
AU4987497A (en) Polyhalophosphazene solutions stable against gelation
KR880002524A (ko) 니코란딜 외용제
DE69613370D1 (de) Zusammensetzung und verfahren zur verstärkung von elektrotransport-wirkstoffzufuhr
BR112021023276A2 (pt) Cartucho compreendendo nicotina e um solvente imiscível em água
RU94010496A (ru) Ноотропное средство и лекарственный состав ноотропного средства
EP1245655A3 (en) Thermosetting coating composition and coating film forming method using the same
WO2001049273A3 (de) Pharmazeutische zusammensetzung zur transdermalen verabreichung von hormonen mit einem permeationsverbessernden zusatzstoff
KR910002792A (ko) 1-치환된-2-(3-아미노-1-프로피닐)피롤리딘 유도체, 그에 의한 중추 콜린성 기능 장해 치료 방법 및 그로구성되는 제약학적 조성물
WO1996032134A3 (de) Konjugat aus einem wirkstoff, einem polyether und ggf. einem nicht als körperfremd angesehenen, nativen protein
BR0112150A (pt) Veìculo para aplicação de compostos quìmicos em madeira

Legal Events

Date Code Title Description
FA Abandonment or withdrawal